Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Participation in NAMA

19 Jul 2010 16:27

RNS Number : 5754P
Bank of Ireland(Governor&Co)
19 July 2010
 



NAMA19 July 2010

 

Update on Bank of Ireland Group's Participation in the National Asset Management Agency ("NAMA")

 

Bank of Ireland Group has completed and submitted to NAMA all of the due diligence material in respect of its Tranche 2 loans and associated derivatives amounting to €2.3bn in nominal value. These loans comprise €1.1bn of land and development loans and €1.2bn of associated loans. The nominal value of the consideration to be received for these loans is expected to be approximately €1.5bn resulting in an estimated discount to gross book value (before impairment provisions) on these loans of approximately 34.9%.

 

As at 19 July 2010, Bank of Ireland Group has transferred €1.8bn (before impairment provisions) of these Tranche 2 loans to NAMA, comprising €1.0bn land and development loans and €0.8bn associated loans. The nominal value of the consideration received for these loans transferred amounted to €1.1bn in Government guaranteed bonds and non-guaranteed subordinated bonds resulting in a gross loss on book value of approximately €0.7bn1 and an estimated discount to gross book value on these loans of approximately 38.5%. The remaining Tranche 2 loans, which predominantly comprise associated loans, are expected to transfer to NAMA in due course.

 

As previously advised, the gross loss on disposal of Bank of Ireland Group Eligible Bank Assets to NAMA will be a function of three factors: the quantum of those loans, the mix of those loans, as between land and development and associated loans, and the discount that would apply to those loans. The Group announced on 26 April 2010 that it believed that the discount on the total portfolio of €12.2bn expected to transfer to NAMA would be within the guidance of €4.8bn (before impairment provisions of €2.8bn at 31 December 2009) provided at the Extraordinary General Court of the Bank on 12 January 2010. The Group made this statement on the basis of the discount arising on Tranche 1 coupled with the results of a valuation exercise on a sample of €6.0bn (approximately 50% of the loans which the Group expects to transfer to NAMA). On the basis of the results of Tranche 1 and the anticipated results of Tranche 2 outlined above, the Group does not expect any material difference to the position announced on 26 April 2010.

 

However, as previously advised, significant uncertainties still remain as to the final discount which will be applicable to Bank of Ireland Group. The Group will only be able to accurately quantify the ultimate gross loss on the transfer of all the Bank of Ireland Eligible Bank Assets to NAMA on completion of the relevant due diligence and the transfer of all the loans to NAMA.

 

1 Prior to (i) any impairment previously recognised by the Group, (ii) the fair value adjustments in respect of any consideration received, (iii) any provision that may be required under accounting standards due to the ongoing cost of servicing these assets on behalf of NAMA, and (iv) taking account of the costs of the transfer.

 

For further information, please contact:

John O'Donovan

Group Chief Financial Officer

+353 (0) 76 623 4703

Andrew Keating

Director of Group Finance

+353 (0) 1 637 8141

Dan Loughrey

Head of Group Corporate Communications

+353 (0) 76 623 4770

 

 

Forward Looking Statement

This document contains certain forward looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the Group) plans and its current goals and expectations relating to its future financial condition and performance and the markets in which it operates. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', or other words of similar meaning. Examples of forward looking statements include among others, statements regarding the Group's future financial position, income growth, business strategy, projected costs, projected impairment losses, capital ratios, margins, future payment of dividends, the outcome of the current review of the Group's defined benefit pension schemes, estimates of capital expenditures, discussions with Irish, European and other regulators and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties relating to the performance of the Irish and UK economies, property market conditions in Ireland and the UK, costs of funding, the performance and volatility of international capital markets, the expected level of credit defaults, the impact of the National Asset Management Agency, the Group's ability to expand certain of its activities, development and implementation of the Group's strategy, including the ability to achieve estimated cost reductions, competition, the Group's ability to address information technology issues, and the availability of funding sources. Any forward looking statements speak only as at the date they are made. The Group does not undertake to release publicly any revision to these forward looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKUVRROABAAR
Date   Source Headline
19th Dec 20119:55 amRNSSale of Burdale and Deleveraging Update
8th Dec 20115:00 pmRNSEBA Capital Exercise
2nd Dec 201110:12 amRNSSubordinated Liabilities Order
2nd Dec 20117:23 amRNSTender Offers - Results Announcement
2nd Dec 20117:06 amRNSTender Offer Results
28th Nov 20117:02 amRNSDeleveraging Plan Update
23rd Nov 20117:00 amRNSSubordinated Liabilities Order
21st Nov 20113:52 pmRNSTender Offer - (Replacement)
21st Nov 20112:13 pmRNSTender Offer
21st Nov 20112:12 pmRNSTender Offer
11th Nov 201111:05 amRNSInterim Management Statement
3rd Nov 20113:50 pmRNSRepurchase
19th Oct 20114:50 pmRNSForm TR1
19th Oct 20114:50 pmRNSForm TR1
19th Oct 20114:50 pmRNSForm TR1
19th Oct 20114:49 pmRNSForm TR1
19th Oct 20114:49 pmRNSForm TR1- NPRFC
17th Oct 20113:08 pmRNSCompletion of Investment in Bank of Ireland
14th Oct 20116:19 pmRNSDeleveraging Plan Update
6th Oct 20112:57 pmRNSRepurchase
23rd Sep 20112:47 pmRNSTender Offer - Results Announcement
16th Sep 20114:35 pmRNSPrice Monitoring Extension
13th Sep 201111:21 amRNSRepurchase
9th Sep 201111:52 amRNSResult of EGM
31st Aug 20115:13 pmRNSTotal Voting Rights
31st Aug 201111:36 amRNSNotice of Results of Meeting
26th Aug 20115:06 pmRNSRepurchase
26th Aug 20114:44 pmRNSRepurchase
24th Aug 20114:52 pmRNSRule 9 Waiver Approval and Notice of EGC
24th Aug 201111:31 amRNSCommencement of Tender Offer
19th Aug 201111:26 amRNSRepurchase
18th Aug 20119:55 amRNSForm TR1
17th Aug 201110:05 amRNSForm TR 1
16th Aug 20116:11 pmRNSForm TR1
15th Aug 201111:49 amRNSTotal Voting Rights
15th Aug 20117:00 amRNSMain Securities Market Notice
10th Aug 20116:22 pmRNSConversion of Allotment Instruments
10th Aug 20116:22 pmRNSDelayed Settlement Security Results
10th Aug 201111:58 amRNSForm TR1
10th Aug 20117:00 amRNSHalf Yearly Report
9th Aug 20113:47 pmRNSDelayed Settlement Security Results
3rd Aug 20116:15 pmRNSForm TR1
3rd Aug 20116:00 pmRNSForm TR1
3rd Aug 20115:45 pmRNSForm TR1
3rd Aug 20113:04 pmRNSDirector/PDMR Shareholding
2nd Aug 20114:09 pmRNSUpdate on EU Restructuring and Viability Plan
2nd Aug 201112:57 pmRNSRepurchase
1st Aug 201112:18 pmRNSRepurchase
29th Jul 20113:55 pmRNSTotal Voting Rights
29th Jul 20112:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.